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Abstract 
Background. A comprehensive meta-analysis to identify the proportions of comorbid 
personality disorders (PD) across the major subtypes of anxiety disorders (AD) has not 
previously been published. 
Methods. A literature search identified 125 empirical papers from the period 1980-2010 
on patients with panic disorders, social phobia, generalised anxiety, obsessive-compulsive 
(OCD) and post-traumatic stress disorder (PTSD). Several moderators were coded. 
Results. The rate of any comorbid PD was high across all ADs, ranging from .35 for PTSD 
to .52 for OCD. Cluster C PDs occurred more than twice as often as cluster A or B PDs. 
Within cluster C the avoidant PD occurred most frequently, followed by the obsessive-
compulsive and the dependent PD. PTSD showed the most heterogeneous clinical picture and 
social phobia was highly comorbid with avoidant PD. A range of moderators were examined, 
but most were non-significant or of small effects, except an early age of onset, which in social 
phobia increased the risk of an avoidant PD considerably. Gender or duration of an AD was 
not related to variation in PD comorbidity. 
Limitations. Blind rating of diagnoses was recorded from the papers as an indication of 
diagnostic validity. However, as too few studies reported it the validity of the comorbid 
estimates of PD was less strong. 
Conclusions. The findings provided support to several of the proposed changes in the 
forthcoming DSM-5. Further comorbidity studies are needed in view of the substantial 
changes in how PDs will be diagnosed in the DSM-5.  
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Comorbidity of Personality Disorders in Anxiety Disorders: A Meta-Analysis of 30 Years 
of Research 
Anxiety disorders (ADs) are one of the most common mental disorders with a 12-
month prevalence of 18% and a lifetime prevalence of about 30% (Kessler et al., 2005a; 
Kessler et al., 2005b). Depending on the nature and severity of an AD, the concurrent 
debilitation of daily functioning and quality of life may become substantial (Ghaedi et al., 
2010; Lochner et al., 2003). As avoidance of situations and/or other people are the cardinal 
behavioural symptoms of ADs, the immobilisation and isolation tend to increase over time. 
This eventually impedes the quality of social relationships and support (Hickey et al., 2005; 
Stein and Kean, 2000), which in combination with the primary AD symptoms contribute to 
the chronic course of the disorder (Beard et al., 2010; Perkonigg et al., 2005; Rubio and 
Lopez-Ibor, 2007; Wittchen, 2002), particularly if left untreated. 
The comorbidity of other mental disorders appears to be the rule rather than an 
exception (Barlow et al., 1986), which partly derives from the secondary functional problems 
arising over time. In a study by Sanderson, DiNardo, Rapee and Barlow (1990), up to 70% of 
the patients had at least one additional axis I diagnosis. The high comorbidity is striking. 
However, such estimates may be inflated as the current diagnostic system (i.e., DSM-IV or 
ICD-10) largely neglects communality in symptom clusters across diagnostic groups. 
Nevertheless, mental disorder comorbidity is considered negative for the natural course of 
illness by implying additional kinds of dysfunction (Coryell et al., 1988) depending on 
whether it is a disorder of mood, substance abuse or personality (Ansell et al., 2011; Brown 
and Barlow, 1992). These three are the most common comorbid disorders. 
Comorbid depression mainly involves anhedonia and reduced motivation. Such 
clinical features may strongly temper the effects of treatment (Spijker et al., 2001), and in 
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particular psychotherapy treatments requiring own efforts, such as behavioural homework 
tasks commonly used in for instance cognitive-behavioural therapy. A substance abuse 
disorder may represent a coping behaviour strategy and a negative reinforcement factor 
counteracting change in automated avoidance behaviour. This paper focuses however on the 
proportions of comorbidity of axis II personality disorders (PD). Such comorbidity may more 
profoundly affect the prognosis and outcome of an AD compared to any other axis I comorbid 
diagnoses (Reich, 2003; Telch et al., 2011).  
One distinction between axis I and II comorbid disorders seems to be in terms of 
severity and complexity. First, the degree of fear and phobic avoidance (Dreessen et al., 1994; 
Kose et al., 2009) is usually more pronounced in patients with axis II compared with axis I 
comorbidity, as well as the level of general psychopathology (Dreessen et al., 1994; Ozkan 
and Altindag, 2005). This is also reflected in analyses of health care costs showing that axis II 
PD patients represent a markedly higher economic burden to the health care system than for 
example depression and anxiety patients (Soeteman et al., 2008). Moreover, having a PD 
represents a strong vulnerability factor for developing other axis I disorders (Stein et al., 
1993). Second, treatment of comorbid PDs are normally more complex and less optimistic 
than treatment of axis I comorbidities due to less favourable outcomes (Reich, 2003; Slaap 
and den Boer, 2001; Telch et al., 2011), higher drop-out rates (Sanderson et al., 2002), less 
positive patient expectations (Martino et al., 2012) and more challenges with establishing a 
durable and flexible therapeutic alliance (Bienenfeld, 2007; Martino et al., 2012). 
Furthermore, the degree of comorbid psychosocial impairment depends on the type of PD. For 
example in a study of 668 PD patients, Skodol et al. (2002) reported a higher degree of 
impairment among schizotypal and borderline patients than among obsessive-compulsive or 
avoidant PD patients. 
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Several reviews of general associations between PDs and ADs have been published 
(Bienvenu and Stein, 2003a; Brandes and Bienvenu, 2009; Brooks et al., 1989; Stein et al., 
1993; Van Velzen and Emmelkamp, 1999). The general conclusions from these reviews are 
that the comorbid frequency of PDs among patients with an AD diagnosis vary considerably, 
but that the proportions are highest in the avoidant, dependent and compulsive PDs (cluster 
C), and smaller in the schizoid, schizotypal and paranoid PDs (cluster A) and the dramatic, 
borderline and anti-social PDs (cluster B). Patients with cluster A or cluster B PDs also 
appear to have a poorer treatment response than cluster C PD patients (Hansen et al., 2007; 
Noyes et al., 1990). 
Very few meta-analyses on the same comorbidity have been published. To the best of 
our knowledge there is only one previous meta-analysis by Ng and Borenstein (2005). They 
specifically examined the comorbidity of a dependent PD (mean r = .11). However, the ratio 
varied considerably between AD diagnostic groups, with panic disorder, obsessive-
compulsive disorder (OCD), agora- and social phobia showing a higher prevalence of PD, 
while generalised anxiety disorder (GAD) and post-traumatic stress disorder (PTSD) showed 
no relationship with PD. The study was also criticised (Holmbeck and Durlak, 2005) for using 
a PD rather than an AD as the main inclusion criteria. The lack of previous meta-analyses 
using AD as the prime inclusion criteria, as well as studies that summarises the comorbidity 
of a PD across all AD diagnostic groups was therefore the main impetus for the present study. 
Additionally, we present data as proportions (equal to percentages), which represents a more 
user-friendly and intuitive effect size statistic. 
 
Associated dysfunctions with PD and expected rates of comorbidity across the AD 
diagnoses 
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The patterns of dysfunction and severity of a comorbid PD depend of the type of PD 
(Ansell et al., 2011). Panic disorder patients with or without agoraphobia are usually strongly 
confined to their home due to rigid avoidance of public, enclosed or open spaces (Rodriguez 
et al., 2007), hence constricting mobility and social participation. As avoidance is one of the 
core symptoms of a panic disorder, the avoidant PD is also one of the most frequent comorbid 
PDs (Brooks et al., 1989). An avoidant personality preference easily intensifies the primary 
anxiety problems due to the loss of exposure to potentially corrective experiences. A 
dependent PD is less common, but if present, the patient may develop an undue reliance on 
another person, hence representing a safety behaviour strategy. The undue reliance also 
affects reciprocity in the relationships with other people, which over time constrict the social 
network. Patients with a borderline PD have more intense panic attacks, and they also attract a 
lot more attention and concern from other people. It is also regarded as the single PD with the 
poorest prognosis for a successful treatment of a panic attack disorder (Nurnberg et al., 1989). 
Patients with social phobia are overly afraid of negative evaluations and social 
embarrassments. Hence, they avoid or at least endure with great pain any situations that 
involve visibility or responsibility. The protracted avoidance and social withdrawal is also 
presumed as the prime reason for the lower socioeconomic status often characterizing this 
group (Stein and Kean, 2000; Vorcaro et al., 2004). The avoidant PD is the most frequently 
occurring comorbid condition (Tillfors and Ekselius, 2009), which is expected considering the 
strong phenomenological overlap between these two diagnoses (Brooks et al., 1989; Reich, 
2000; Rettew, 2000). However, in a review by Rettew (2000) the comorbidity estimates 
varied extremely, from 25% to nearly 100%. Clearly, this variation must be due to other 
factors than sampling error alone. Hence, we expected the avoidant PD to be most prevalent 
comorbid PD in social phobia. Moreover, this PD is particularly related to a poor treatment 
outcome (Turner, 1987). 
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Patients with GAD experience constant worry and tension as their prime symptoms. 
Procrastination, avoidance behaviour and frequent reassurance seeking from others are typical 
compensatory strategies (Clark and Beck, 2010). Patients with social phobia and GAD 
appears to have higher rates of comorbidity than patients with panic disorders (Blashfield et 
al., 1994; Jansen et al., 1994). Cluster C PDs appears to be the most prevalent in GAD, 
particularly the avoidant and the OCD PD subtypes (Garyfallos et al., 1999). We therefore 
expected these to have the highest comorbid estimates. Like for social phobia, the avoidant 
PD also appear to be the most relevant PD predicting a poorer treatment outcome (Massion et 
al., 2002). 
PTSD-patients are particularly prone to lapse into unhealthy behaviours by overusing 
alcohol or drugs to alleviate traumatic memories (Hidalgo and Davidson, 2000; Leeies et al., 
2010), which over time leads to a poorer physical health and an overuse of health care 
services (Greenberg et al., 1999). A connection between PTSD and the axis II disorders 
avoidant (Ansell et al., 2011), obsessive-compulsive (Pietrzak et al., 2011) and borderline PDs 
have been established (Bienvenu and Stein, 2003b; Pagura et al., 2010; Shea et al., 1999), but 
also with paranoid and schizotypal PDs (Crepulja and Franciskovic, 2010; Pietrzak et al., 
2011). Paranoid traits are understandable as PTSD patients often feel a constant need to be 
vigilant and on guard. However, the reported proportions vary across studies, to which the 
present meta-analysis may provide more reliable estimates. 
OCD-patients are chronic sufferers who experience major impairment especially 
related to physical/occupational and emotional functioning (Hollander et al., 1996; Hollander 
et al., 2010). The degree of any PD has varied from 66% (Stein et al., 1993) to as low as 4% 
(Joffe et al., 1988), with the OCD PD as the most frequent comorbid condition (Alnaes and 
Torgersen, 1988; Samuels et al., 2000; Skodol et al., 1995). Obviously, a comorbid OCD PD 
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may introduce a “double burden” in terms of intensified needs for order and perfection when 
performing OCD related checking or rituals in order to reduce anxiety. 
From this brief outline of the literature, it is evident that a concurrent PD may impede 
both treatment and outcome of an AD, as well as possibly raising health care costs. The lack 
of previous meta-analyses covering all ADs, call for an empirical review to summarise and 
evaluate the current standing in the literature. It is also evident that the large between-study 
variation in the comorbid proportions of PDs across the various ADs, invite for a search for 
moderators that may explain this variability. 
In the current study we examined the impact of diagnostic system (DSM-III-R versus 
DSM-IV), diagnostic methods (interview versus questionnaire), sample characteristics 
(patients receiving inpatient versus outpatient treatment), mean age of onset of AD and 
duration of AD. We expected higher comorbidity estimates from studies based on 
questionnaire data compared to structured interviews as that has been reported from PD 
comorbidity studies on for example eating disorders (Ramklint et al., 2010; Rosenvinge et al., 
2000). Literature comparing the PD comorbidity between in- and outpatient samples is very 
scarce, except some findings indicating a higher degree of cluster B comorbidity in inpatients 
(Melartin et al., 2002). Hence, a clear-cut prediction could not be made, but the degree of 
comorbidity was expected higher among inpatients based on the psychiatric worse condition 
that an inpatient admission implies, particularly among patients with cluster B PDs. An early 
age of onset of an AD appears negative as it is associated with a longer duration of illness and 
a higher general symptom load in OCD (Wang et al., 2012), a history of childhood abuse a 
and worse clinical outcome in GAD (Goncalves and Byrne, 2012), as well as generally higher 
comorbidity with other ADs (Klein Hofmeijer-Sevink et al., 2012). Moreover, early onset has 
also been related to higher comorbidity estimates between OCD and OCD-PD (Coles et al., 
2008), between GAD and any PD (Garyfallos et al., 1999), and between social phobia and 
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avoidant PD (Holt et al., 1992). Since the duration of an AD is partly related to the age of 
onset, we expected that an early age of onset and a longer duration of AD would imply a 
higher degree of comorbid PDs. 
Hence, the paper had two primary aims: First, to compute mean weighted proportions 
of co-morbidity between the major axis I ADs and all axis II PDs. Second, to examine 





The current study was part of a larger meta-analytic project on the comorbidity 
between axis-I symptom disorders (depression, anxiety and eating disorders) and axis-II PD. 
The databases PsychINFO, Embase and Medline were searched for scientific papers on the 
comorbidity between anxiety and personality disorders published in the period between 1980 
and 2010. The following keywords were used: “anxiety disorder" OR "anxiety disorders" OR 
phobia OR "panic disorder" OR "obsessive-compulsive disorder" OR "posttraumatic stress 
disorder" AND "personality disorder" OR "personality disorders" AND co-morbidity. The 
search yielded 1726 articles. By screening the abstract of the papers and excluding studies of 
patients recovered from an AD, or where the AD was comorbid to other axis-I diagnoses, the 
list was reduced to 71 papers. Additional 86 articles were located from the reference lists of 
17 review papers that we identified (i.e., Baer et al., 1992; Bienvenu and Stein, 2003b; 
Eskildsen et al., 2010; Keeley et al., 2008; Marshall, 1996; Mavissakalian, 1990; McLaughlin 
and Mennin, 2005; Mennin and Heimberg, 2000; Merikangas and Angst, 1995; Ng and 
Bornstein, 2005; Papp et al., 1990; Pigott, 1998, 2003; Reich, 2009; Stein et al., 1993; 
Summerfeldt et al., 1998; Tillfors and Ekselius, 2009). As the present study was part of a 
larger meta-analytic project, 27 additional papers were found in addition to seven reviews 
(i.e., Dreessen and Arntz, 1998; Maser, 1998; Noyes, 2001; Reich, 2000, 2003; Ruegg and 
Frances, 1995; Vaglum, 2000), further extending the list with 59 papers. A total of 243 
published articles were identified using these procedures.  
Inclusion criteria 
Empirical papers were eligible for inclusion in the meta-analysis if: (1) patients were > 
18 years old, (2) the AD was the primary diagnosis, (3) information about the proportion of 
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comorbid PD was available, and (4) English or German language were used. Treatment 
studies were included if the proportion of PD was reported at baseline. Thus, 118 papers were 
excluded, yielding a final pool of 125 papers. 
Coding procedure 
From each study we coded general information about the article: author, year and 
country of publication, information about the sample (number of patients, proportion of 
women and mean age). Comorbid events of PD were entered as proportions. ADs were coded 
as panic disorder with (panic -a) or without agoraphobia (panic +a), social phobia, OCD, 
PTSD or GAD.  
In accordance with the DSM-IV (APA, 1994), PD clusters were coded as: Cluster A 
(paranoid, schizoid and schizotypal PD), cluster B (antisocial, borderline, histrionic and 
narcissistic PD) and cluster C (avoidant, dependent and obsessive PD). If a PD diagnosis was 
based on the International Classification of Diseases (ICD, 1992), the equivalent DSM-IV 
diagnosis was used (e.g., anxious PD coded as avoidant PD, and emotional unstable PD as 
borderline PD). Proportions of any kind of PD (any PD), of the clusters A, B and C, and each 
of the specific PDs were coded. 
As potential moderators, information about the mean age of onset of an AD, duration 
of the AD and duration of the PD (in years) was coded, as well as recruitment sample/type of 
patients (inpatients, outpatients, inpatients and outpatients, or primary care/community), 
gender distribution, diagnostic method for deciding an anxiety and a personality disorder 
(interview, questionnaire or a clinical assessment) and diagnostic system used (DSM: -III, -
III-R, IV or -IV-TR, ICD: -9, -9-CM or -10). Information about blind scoring for AD and PD 
were also coded as yes, no or not reported. 
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Coding procedure 
Two psychology students (Øvergård and Kaiser), trained by Rosenvinge and Friborg, 
coded the papers. The training included definitions and examples of the coding categories for 
all variables and an introduction to the data management process. Furthermore, for training 
purposes five randomly selected articles were independently coded by the raters and 
compared to the results of one supervisor. The number of disagreements was few, and if 
present, they were discussed with the supervisors until a consensus was reached. The inter-
rater reliability was examined in a similar meta-analysis (Friborg et al., 2012) between the 
same student coder (Øvergård) and the first author (Friborg), and found highly satisfactory.  
Statistics 
The meta-analysis was conducted using the programme Comprehensive Meta-
Analysis version 2.2.057 (released December 2010) (Borenstein et al., 2005a). SPSS v18.0 
was used for other statistical analyses. The mean weighted event rate was estimated as 
proportions (number of PD cases/sample size), and used as effect sizes in the analyses. 
Calculations were based on a random effects model as the proportions may vary across 
studies due to other factors than random error, like illness severity or duration of an illness. 
Hence, variance in proportions may be partitioned in two sources: a) variance within studies 
(ε, random/sampling error), and b) variance between studies (θ, variance in true proportions) 
(Borenstein et al., 2005a; Hedges and Vevea, 1998). Each study was weighted by calculating 
the inverse of these variance components: 1 / (ε+θ). Small studies imply a larger within-study 
variance component (ε = σ
2
/n), thus lowering the weight given to data from small samples. A 
Q test statistic may be calculated to test whether the variance between studies is significantly 
different from zero, thus indicating that variation in proportions truly exists from which 
predictors (or moderators) may be sought. Furthermore, the random effects model reduces the 
type I error rate, hence enhancing the generalizability of the findings (Field, 2003; Lipsey and 
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Wilson, 2001). An analogous Q-test statistic for between-group differences may be conducted 
to examine whether the observed difference in proportions between two samples, divided by a 
categorical predictor (moderator), are significantly different. Continuous moderators were 
examined by conducting meta-regression analyses. The random effects slope parameter was 
estimated using the unrestricted maximum likelihood method (Borenstein et al., 2005b). 
Results 
Sample characteristics 
Most studies were conducted in America (62 studies) and Europe (58 studies). Only 
seven studies came from other parts of the world. The five year publication rate was relatively 
steady with 19, 37, 22, 18 and 29 studies appearing within each period. The total number of 
patients in the 125 studies was 14 612. The study details are provided in Table 1. Most studies 
were conducted on outpatient samples (49%), while inpatient, a combination of 
inpatient/outpatient samples and recruited/community samples constituted 37%. Eighteen 
studies (14%) did not provide unambiguous information about sample type.  
More women than men had panic disorders and GAD, while more men than women 
suffered from a PTSD. These numbers are not estimates of prevalence, but of the gender 
distribution in the clinical/recruited samples. For most ADs, the onset of illness was in the late 
twenties, except social phobia and OCD which debuted during the teenage years and the early 
twenties, respectively. Hence, the mean duration of illness was longer for these two disorders, 
in addition to GAD. PTSD, agoraphobia and OCD occurred most often in inpatients samples, 
while social phobia and panic disorder patients more often came from recruited samples. 
The most common diagnostic system to diagnose an AD or a PD was the DSM-
III/DSM-III-R (AD: 70.5% - PD: 73.4%), followed by the DSM-IV/IV-TR (AD: 27% - PD: 
24.2%) and ICD-9/10 (AD: 2.4% - PD: 2.4%). The preferred assessment method for AD and 
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PD was a structured interview (AD: 82.5% - PD: 71.2%), followed by a subjective clinical 
assessment (AD: 13.5% - PD: 7.2%), questionnaires (AD: 1.6% - PD: 14.4%), and a 
combination of interview and questionnaires (AD: 2.4% - PD: 7.2%). 
--- Table 1 --- 
Comorbidity with personality disorder (PD) clusters 
The comorbidity rate (mean proportion) of any PD (patients having at least one 
comorbid PD diagnosis) was high across all the subtypes of AD, ranging from .35 (PTSD) to 
.52 (OCD). As expected, the comorbidity rate of cluster C PDs combined across all ADs (.39) 
was significantly higher than cluster B PDs (.19) and cluster A PDs (.13) (Q2 = 86.5, p < 
.001). The difference between cluster A and B PDs was significant (Q = 4.62, p = .03), but of 
small magnitude. The number of studies providing proportion estimates on the cluster level 
was however sparse, except for panic/agoraphobia and OCD showing a similar pattern across 
the cluster levels. A significant difference in the cluster C PD comorbidity was evident 
between panic disorders without (.22) and with agoraphobia (.38) (Q = 5.23, p < .02). 
--- Table 2 --- 
Comorbidity with specific PD 
Of the estimates of comorbidity between a specific PD and the separate ADs (Table 3) 
social phobia had the highest rate of occurrence with the avoidant subtype (.46). Second came 
PTSD showing an elevated comorbid pattern across a number of specific PDs, notably 
paranoid, avoidant, borderline and OCD (range: .22-.26). All other specific PDs occurred at 
significantly lower rates (range: .03-.11). For the remaining ADs, panic disorders (with and 
without agoraphobia), GAD, OCD and AD-NOS, the level of cluster A and B specific PDs 
were generally low (range: .02-.11), while the cluster C specific PDs were observed more 
often (range: .08-.20). The avoidant and the OCD subtypes occurred more often than the 
dependent subtype. The comorbidity estimates in Table 3 were stable for most ADs as the 
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confidence intervals were small (generally within a window of 10%). PTSD on the other hand 
had wide confidence intervals, indicating a comorbidity of a considerable heterogeneous 
nature (e.g., ranging from .07 - .64 for the paranoid PD). 
Moderators analyses 
Due to a large number of possible moderator effects a selection was made for findings 
reporting (1) a significant heterogeneity statistic (Qwithin), and (2) containing a minimum of 
three studies within each comparison group. 
Sample (inpatients vs. outpatients): Among panic disorder patients, the proportion of 
an avoidant PD was higher among inpatients (  = .31, k = 3) than outpatients (  = .16, k = 17) 
(Q = 4.62, p < .05). This difference was opposite for narcissistic PD which was less frequent 
among inpatients (  = .01, k = 3) than outpatients (  = .09, k = 12) (Q = 8.90, p < .01). Among 
OCD anxiety patients, the proportion of an OCD PD was lowest among inpatients (  = .12, k 
= 3), higher among outpatients (  = .21, k =16), and highest among patients receiving both 
treatment types (  = .31, k = 3). Only the difference between inpatients and both treatment 
types was significant (Q = 3.94, p < .05). No other statistically significant differences 
emerged. 
Diagnostic system: There was a trend toward lower proportions of a comorbid PD 
among patients with social phobia or OCD if diagnoses were based on the DSM-IV compared 
with -III/III-R (Table 4, first and second column). For panic disorders the patterns were more 
mixed. Cluster C OCD PDs occurred more often if the AD diagnosis was based on the DSM-
III-R or the DSM-IV compared with the DSM-III. However, diagnoses of a PD based on the 
DSM-IV yielded lower comorbid estimates than diagnoses based on the DSM-III or the DSM-
III-R.  
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Diagnostic method: AD diagnoses based on a clinical assessment yielded higher 
comorbid estimates within all PD clusters compared to a structured interview (Table 4, second 
last column). This tendency was in practice only evident for the OCD AD. The differences 
were largest within the schizotypal and the avoidant PDs. Questionnaire methods were rarely 
used to diagnose an AD. PD diagnoses based on questionnaires also yielded higher comorbid 
estimates than structured interviews (Table 4, last column). These differences were generally 
not large, except for cluster C PDs (notably the avoidant PD) among OCD anxiety patients. 
Data on clinical assessment were not suited for an empirical analysis. 
Blind rating of AD and PD: As only two and seven studies provided positive and 
negative information about blinding, respectively, the effect of this moderator could not be 
analysed. 
 
Meta-regressions examining continuous moderators 
The following moderators were examined: Gender, mean age of onset and duration of 
an anxiety disorder. As the CMA program converts proportions to logits, an antilog 















Gender: This was reported as proportion of women participating in the studies. 
Sufficient data were only available for panic disorders, social phobia and obsessive-
compulsive disorder. However, no meta-regression results were statistically significant. 
Mean age of onset: An earlier mean age of onset of social phobia was related to a 
higher comorbidity of cluster C PDs, particularly an avoidant PD (β0 = 3.77, β1 = -.227, p < 
.001, k = 16), but also the dependent PD (β0 = 3.74, β1 = -.377, p < .01, k = 9). Calculating the 
comorbidity rate for 15, 18, 25 and 30 years of mean age using the above formula, revealed an 
avoidant PD comorbidity rate of 59.0%, 42.2%, 13.0% and 4.6%, and a dependent PD rate of 
12.8%, 4.5%, 0.3% and 0.1%, respectively. 
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Duration of AD: Duration of illness only moderated the comorbidity between panic 
disorders and schizotypal PD (β0 = -4.35, β1 = .187, p < .01, k = 11), indicating a higher 
comorbidity the longer the duration of the panic disorder. The effect was however small, 
rising from 1.5% to 7.7% from 1 to 10 years. 
Discussion 
This present meta-analysis on the comorbidity of personality disorders (PD) in the 
major subtypes of anxiety disorders (AD), i.e., agoraphobia/panic disorder, generalised 
anxiety disorder (GAD), social phobia, post-traumatic stress disorder (PTSD), obsessive-
compulsive (OCD) and unspecified AD was based on 125 studies. Most data were collected 
from outpatient samples. Overall, the risk of having at least one comorbid PD (any PD) was 
high across all subtypes, ranging from 35% in PTSD to 52% in OCD. On the cluster level, 
cluster C PDs (avoidant, dependent and obsessive-compulsive) were observed more than 
twice as often as cluster A (paranoid, schizoid, schizotypal, anti-social) or cluster B 
(borderline, histrionic, narcissistic) PDs. Within cluster C, the avoidant PD was the most 
frequent comorbid condition, followed by OCD and the dependent PD. These cluster level 
differences were only valid for panic disorders and OCD as the other AD studies provided 
less information about the PD cluster level comorbidity. As the cluster levels will not be 
retained in the DSM-5 due to weak empirical support (Sheets and Craighead, 2007), this is not 
relevant to address in future research. 
As for the comorbidity of specific PDs, social phobia had the highest proportion of a 
an avoidant PD. For the remaining ADs, except PTSD, the comorbidity rates for the specific 
PDs were significantly lower. The heterogeneity statistics were generally significant across 
most subtypes of AD and PD. This indicates that the between study variance is a result of 
other factors than sampling error, and that moderators may be sought. However, as the 
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confidence intervals generally ranged within a window of 2-12%, except for PTSD and in a 
few other cases, the variance in PD comorbidity was considered too low to be of major 
clinical concern. 
Compared to all other AD subtypes, patient groups suffering from PTSD had a highly 
different comorbidity profile with a mixture of PD comorbidity, mainly paranoid, avoidant, 
borderline and the OCD PD. The confidence intervals were large, but unfortunately, none of 
the moderators examined in the present study explained this variation. Clearly, PTSD stands 
out as clinically more heterogeneous in nature compared with the other ADs. This is in line 
with other research pointing out the considerable heterogeneous clinical picture characterizing 
this patient group (Suvak and Barrett, 2011). Moreover, the heterogeneity may be explained 
by the large variety in the nature and impact of traumatic exposures, and the fact that the issue 
of identifying core features of the disorder is still considered unresolved (Brewin et al., 2009). 
The present study thus confirms that the symptom overlap and heterogeneity often observed 
in PTSD involve a considerable mixture of personality traits and disorders. Interestingly, the 
paranoid PD was the most comorbid condition although it is suggested removed from the 
DSM-5. However, due the exceptionally high comorbidity variation of this PD compared with 
the other subtypes, and the lack of research on paranoid PDs in general (Skodol, 2012) that 
may substantiate this variation, its removal seems justified. The PD section in DSM-5 is 
meant to be frequently revised and as new revisions are issued it seems sensible to initiate 
continuous studies on whether this subtype may yield more substantial information.  
Another noteworthy finding was that OCD AD patients did not have a noticeably 
higher occurrence of a comorbid OCD PD (.20) compared with the other cluster C PDs, 
notably the avoidant PD (.17). This may stand in contrast to several researchers claiming a 
particularly strong comorbid relation between OCD AD and OCD PD (Alnaes and Torgersen, 
1988; Diaferia et al., 1997; Samuels et al., 2000). Nevertheless, the present estimate came 
19 
close to the proportion reported by Mancebo et al. (2005) in their review of all OCD AD-
OCD PD studies between 1991 and 2004 (not higher than .25). The present estimate did not 
depend on the diagnostic system either (DSM-III-R versus DSM-IV), but it depended to some 
extent on the diagnostic methods used. 
Structured interviews were by far the most often diagnostic method. Although the use 
of subjective clinical assessments and questionnaire methods were rare, they were used in 
varying degrees across the different AD subtypes and could hence bias the results. We 
examined this possibility by rerunning the analyses in Table 3 after first removing all studies 
using clinical assessments or questionnaires. We observed no noticeable differences from the 
original table as most comorbidity estimates dropped down systematically with only 1-3%. 
Hence, the inclusion of studies using clinical assessments or questionnaires methods did threat 
the validity of the findings, possibly due to the low number of studies and the use of a random 
effects model. The only noticeable exception to this pattern was the comorbidity between 
OCD AD and OCD PD which increased from .20 to .22, while OCD AD-avoidant PD 
dropped down from .17 to .14. Hence, the contention of a particular link between OCD AD 
and OCD PD made by others (Alnaes and Torgersen, 1988; Samuels et al., 2000; Skodol et 
al., 1995) was largely confirmed by the current study. 
Moderator analyses 
The use of different diagnostic systems did not influence the comorbidity estimates in 
a clear-cut manner, although PD diagnoses based on the DSM-IV system appear more 
conservative (lower proportions) than the previous DSM-versions. However, the magnitudes 
were low and should raise no concern for clinical practice. A consistent observation was that 
the DSM-system is widely used in studies of a European origin despite the fact that the ICD-
system is their official diagnostic tool. This may be unfortunate as the failure to use this 
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system prevents across-system comparisons necessary for improvements and empirically 
based harmonization between the ICD and the DSM. 
The use of structured interviews to diagnose a PD led to lower comorbidity estimates 
than the use of questionnaires. This was expected as several other meta-analyses have 
indicated a comparable pattern (Ramklint et al., 2010; Rosenvinge et al., 2000). This effect 
was however only evident for panic and OCD disorders, and not for GAD and social phobia. 
The difference was also more pronounced in the assessment of cluster A and B PD, but less of 
problem for cluster C PDs, which we have no explanation for. Structured interviews for 
diagnosing an AD also yielded a lower comorbidity than clinical assessments. This was only 
evident for the OCD AD, which might imply that a subjective clinical assessment of OCD 
ADs is particularly prone to over-diagnosing of axis II comorbidity. A tentative explanation 
may be connected to the claim that milder forms of autism spectrum disorders and 
neuropsychological deficits occur more often in OCD patients than in other AD diagnostic 
groups (Bejerot, 2007). Certain subtypes of OCD patients, such as hoarders, may stand out as 
particularly odd to clinicians (Samuels et al., 2007), which may contribute to the tendency to 
over-pathologise their unusual personality traits. This argument was partly supported by the 
present study as the schizotypal PD occurred more frequently among OCD patients than 
among agoraphobia, social phobia or GAD patients. 
Of the continuous predictors, gender was not found to influence the comorbidity rates. 
Although a range of gender differences in axis I and axis II disorders are quite common 
(Tadic et al., 2009), gender differences in the degree of PD comorbidity did not receive 
support. Gender differences in the assessment of PD comorbidity may therefore be of less 
concern during clinical assessment. 
An earlier age of onset of an axis I AD predicted an increased degree of PD 
comorbidity for social phobia only. The risk for developing a cluster C PD increased 
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markedly the earlier the patients developed a social phobia disorder. The high comorbidity 
observed in the present study was in line with numerous previous reports indicating a 
phenomenologically very close relationship between social phobia and the avoidant PD 
(Brooks et al., 1989; Reich, 2000; Rettew, 2000). A similar trend was also found for the 
development of a dependent PD, but the degree of comorbidity was quite small in 
comparison. The duration of the AD was examined, but almost all tests were non-significant 
or of a small effect. Hence, for the development of a comorbid PD an earlier age of onset of 
an AD appears to be much more important than the duration of an AD. This highlights the 
importance of early detection and treatment, and in particular of social phobia, to reduce the 
risk for the life-long chronic condition which this combination of disorders implies. 
Implications for DSM-5 
In the provisional drafts for the DSM-5, PTSD is proposed as part of a new cluster 
called “Trauma- and Stressor-Related Disorders” rather than being part of AD as in DSM-IV. 
Our findings support this revision due to the considerably larger heterogeneity in the PTSD 
comorbidity estimates compared with the other subtypes of AD in addition to the larger 
number of comorbid PDs. The clinical picture of PTSD is generally complex and shares a 
range of symptoms with both anxiety and depression disorders. The finding of a paranoid PD 
as a notable comorbid condition also adds weight, which may reflect the hypervigilance these 
patients often report to threat-related stimuli. Another reason for the observed heterogeneity in 
PTSD may be the multitude of stressors that may give rise to a trauma-related disorder, as 
each stressor or trauma may invoke a different pattern of memory intrusions and trauma-
related symptoms, as well as different symptoms of anxiety, depression or grief. 
Panic disorders in the DSM-IV is described as with or without agoraphobia, while the 
DSM-5 proposes to separate these into two separate diagnoses called “Panic Disorder” and 
“Agoraphobia”. The present findings provide tentative support for this separation as the 
22 
frequency of cluster C PDs are significantly larger in panic disorder patients with agoraphobia 
than those not having agoraphobia (Table 2). The empirical support may however be less 
valid as it rests on a cluster model of PDs, which has poor validity (Sheets and Craighead, 
2007). However, as the clinical severity of panic patients with agoraphobia appears more 
pronounced than in those without agoraphobia (Furakawa et al., 2009), and as the presence of 
a comorbid PD is considered highly influential for the natural course and treatment prognosis 
(Reich, 2003; Telch et al., 2011), the proposed separation converges with the present findings. 
Differences in phenomenology and clinical severity of panic disorders and agoraphobia 
should also be better accounted for in DSM-5 by the introduction of a dimensional assessment 
of personality function and pathological personality traits. 
Four of the 10 PDs from DSM-IV are proposed removed from the DSM-5, i.e. the 
paranoid, schizoid, histrionic and dependent PDs (APA, 2010). Based on the current meta-
analysis, removal of the schizoid PD should be the least controversial due to the very low 
prevalence across most AD subtypes in the present study, which also is the case in clinical 
samples in general (Skodol, 2012). The dependent PD is suggested removed due to low 
comorbidity in community samples, high variability in clinical samples and weak construct 
validity (Skodol, 2012). The present comorbidity estimates did not provide any clear-cut 
picture here, but the dependent PD had consistently lower comorbidity estimates than the 
avoidant PD. As avoidance behaviour is the prime behaviour that maintains an anxiety 
disorder, having an avoidant comorbid PD may represent a considerably poorer prognostic 
marker than a dependent PD. The additional benefit of assessing a comorbid dependent PD in 
patients with anxiety disorders may therefore be quite limited, especially among individuals 
with a social phobia. 
A final note concerns the change in the way severity and complexity will be assessed 
in the DSM-5. In the DSM-IV, severity is not assessed separately, and hence, it is not possible 
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to indicate the degree of functional loss caused by a comorbid PD although the individual 
differences within a PD subtype may be large. All patients are assumed to suffer the same 
degree of functional loss. Due to this flaw, different types of PDs have become associated 
with better or worse prognostic indicators or outcomes, such as the schizotypal/borderline 
PDs (worse) compared with the avoidant/OCD PDs (better), without a systematic and 
consistent clinical procedure to support such associations (Skodol et al., 2002). The new 
approach in the DSM-5 of assessing degree of functional loss in terms of self and 
interpersonal functioning, in addition to the specific personality pathological traits, is an 
important step forward. Among other things, it should change the focus on certain PDs as 
more severe or disabling than others and acknowledge that any PDs may be potentially severe 
and complex depending on the degree of functional loss. Future studies may reveal whether 
the new diagnostic system will improve treatment of ADs and the predictive value of outcome 
relevant prognostic factors for these disorders.  
Strengths and limitations 
This is the first meta-analytic review encompassing all major subtypes of ADs, and 
where a large number of included studies made it possible to obtain stable comorbidity 
estimates. Publication bias is of less concern in studies of comorbidity than for example in 
clinical trials as any comorbidity estimate (either low or high) would be interesting. Hence, it 
is not possible to say what a negative result represents, thus reducing the problem of non-
publications of negative results. Several funnel plots were examined, but none of them yielded 
skewed standard error distributions indicative of publication bias. Heterogeneity in the 
findings may also lead to an asymmetrical funnel plot. The combination of significant 
heterogeneity in the present study and lack of asymmetry thus makes publication bias highly 
unlikely. 
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In order to strengthen the validity of the comorbidity estimates, it was recorded from 
the papers whether blind rating of diagnoses had been employed or not. If studies using blind 
rating had provided similar comorbidity estimates as studies using standard diagnostic 
methods, that would have strengthened the validity of the estimates. These analyses were 
however not possible to conduct as too few studies provided data on blind rating. Future 
studies should therefore improve the methodology, or the research field could preferably settle 
on a standard way of assessing the validity of diagnostic ratings. 
Conclusions 
Do we need more studies on the comorbidity of axis-II PDs? Probably not due to 
rather small confidence intervals for panic disorder with agoraphobia, social phobia, GAD 
and OCD. However, the number of studies on pure panic disorders and PTSD are low. As 
PTSD also stand out as a very heterogeneous condition, future studies on comorbidity should 
focus on PTSD and the possible reasons for the considerable heterogeneity observed. On the 
other hand, future PD-comorbidity studies may be needed in view of the considerable changes 
in how PDs are conceived in the drafts for the forthcoming DSM-5. In particular, the new 
dimensional conception of personality traits and general level of functioning may provide new 
insights into the relation between social phobia and avoidant PD, as well as OCD and OCD 
PD. Nevertheless, our finding that a substantial proportion of AD patients also present with an 
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Table 1. Overview of Study Characteristics Depending on Type of Anxiety Disorder 
 N K Women K Age K Onset K Duration K Sample type (%) 
AD  %    In Out I&O RC X 
All studies 14 612 125 54 92 35.8 90 22.5 56 11.5 56 11 49 11 15 14 
Panic –a 882 17 63 10 36.9 9 27.7 4 8.7 3 0 24 19 28 29 
Panic +a 3 303 35 66 29 35.8 28 27.6 20 7.5 19 11 57 03 10 19 
SP 2 122 32 48 26 34.1 26 17.4 17 15.9 17 05 36 01 42 16 
PTSD 2 357 14 37 12 39.7 9 na na 28 25 27 14 06 
GAD 911 16 67 7 42.5 7 28.9 3 12.2 3 04 62 04 20 10 
OCD 3 075 38 55 31 34.0 31 21.3 24 12.1 24 10 56 16 05 13 
Healthy 
control 
1 961 17 57 7 34.9 8 25.4 2 8.2 2 04 75 06 03 12 
Notes. Panic –a = Panic disorder without agoraphobia, Panic +a = Panic disorder with agoraphobia, SP = Social phobia, PTSD = Post-traumatic 
stress disorder, GAD = Generalised anxiety disorder, OCD = Obsessive-compulsive disorder, Other = Anxiety disorders not otherwise 
specified. N = Number of patients, K = Number of studies, na = not available data, In = Inpatient, Out = Outpatient, I&O = Both in- and 
outpatients, RC = Recruited/primary care/community samples, X = Unspecified.
Revised tables with revision marks removed
2 
Table 2. Comorbid Proportions of Any and Clusters of Personality Disorders for Different Anxiety Disorders Based on a Random Effects Model 








CI.95 N K p
 
CI.95 N K p
 
CI.95 N K p
 
CI.95 N K 
All studies .49 .45-.53*** 10 582 87 .13 .09-.18*** 4 640 30 .19 .15-.23*** 5 139 34 .39 .34-.44*** 5 347 35 
Panic –a .41 .33-.49*** 608 13 .14 .05-.32*** 279 4 .16 .09-.28*** 317 5 .22 .13-.34** 317 5 
Panic +a .47 .40-.54*** 2614 30 .11 .08-.16*** 1481 14 .20 .15-.26*** 1794 18 .38 .31-.46*** 1955 19 
SP .48 .39-.56*** 1190 18 .09 .05-.15 322 3 .06 .02-.21*** 392 4 .46 .36-.56* 391 4 
PTSD .35 .21-.52*** 1267 7 .29 .04-.81*** 199 2 .27 .21-.33 199 2 .63 .13-.96*** 199 2 
GAD .47 .39-.56*** 864 14 .07 .03-.16** 378 4 .14 .08-.24** 378 4 .36 .31-.40 378 4 
OCD .52 .45-.59*** 2117 29 .13 .06-.24*** 1122 11 .15 .10-.22*** 1201 12 .34 .26-.42*** 1249 12 
Other 
anxiety 
.44 .35-.53*** 1922 16 .07 .01-.33*** 859 5 .10 .04-.23*** 858 5 .30 .21-.41*** 858 5 
Healthy 
control 
.15 .11-.21 625 5 .03 .01-.09 566 3 .03 .02-.05 565 3 .12 .06-.21 565 3 
Notes. p = Mean weighted proportion of personality disorders, CI.95 = 95% confidence interval. The Qwithin test was used to test for heterogeneity 
in proportions an indicated as significant using asterix: * p < .05, ** p < .01 and *** p < .001. N K = Total sample size (N) and number of 
studies (K). 
3 
Table 3. Comorbid Proportions of Specific Personality Disorders (PDs) for Different Anxiety Disorders Based on a Random Effects Model 
 PDs 
ADs Paranoid Schizoid Schizotyp Antisocial Borderline Histrionic Narcissistic Avoidant Dependent OCD 













































































































































































































































































































Notes. Reported data (ex: .06
.03-.12**
) represent mean proportion of personality disorders, and in superscript, 95% confidence interval and the 
heterogeneity test statistic (Qwithin) indicated as 
*
 p < .05, 
**
 p < .01 and 
***
 p < .001. Total sample size and number of studies [ex: 439 9] 
are reported on the line below.
4 
Table 4. Statistically Significant Dichotomous Moderators of the Random Effects Comorbid Proportion Estimates for the Comorbidity between 
Personality Disorders (PDs) and Anxiety Disorders (ADs). 
ADs 
   PDs 



















       
   Cluster A PDs .08 3 .17 9 .10 5 
1<2**
 na .21 6 .07 3 
2>3***
     
      Paranoid    .04 5 .09 12 .06 5 
1<2*
     
      Schizoid         .02 17 .15 4 
***
 
      Schizotypal    .08 5 .03 10 .02 3 
1>3**
 .02 20 .08 3 
***
 .02 17 .10 4 
***
 
   Cluster B PDs .15 3 .20 11 .21 7 
1<3* 
       
      Histrionic         .06 22 .19 5 
***
 
   Avoidant         .16 26 .25 6 
*
 
   Dependent         .12 26 .26 5 
*
 
   OCD .06 7 .11 19 .14 7 
1<3**
 .05 6 .11 16 .15 5 1<3**     
Social phobia         na  
   Dependent na .12 13 .02 4
 2>3*** 
na .09 12 .03 3 
2>3*
     
GAD   
 
     na  
  Any PD .30 3 .51 8 
** 
       
OCD           
   Schizotypal       .06 20 .22 6 
***
 .05 20 .18 5 
** 
   Antisocial       .02 14 .08 5 
***
   
   Paranoid    .09 5 .07 10 .03 6 
1>3*
     
   Borderline         .06 18 .15 5 
*
 
   Histrionic    .12 7 .07 11 .03 6 
1>3*** 
.05 19 .13 5 
*
   
   Avoidant       .15 18 .38 4 
*
 .14 18 .40 4 
*
 
   Dependent .14 4 .12 9 .06 7
 1>3* 
.19 6 .11 11 .07 6 
1>3**  
.08 19 .21 5 
**






 Panic disorders with and without agoraphobia, D3 = DSM-III, D3R = DSM-III-R, D4 = DSM-IV, I = Interview, CA = Clinical 
Assessment and Q = Questionnaire. * p < .05, ** p < .01. na = not available data. 
